Coronavirus

Pfizer Begins Clinical Trial Of COVID-19 Antiviral Paxlovid In Kids

The drug company announced Wednesday it has started a clinical trial for Paxlovid in kids ages 6 to 17.

Pfizer company logo
Richard Drew / AP
SMS